International food and nutrition policy consultancy EAS will hold a workshop in Brussels this February entitled ‘Building a Regulatory Strategy for Marketing Food Supplements in Europe: The key steps to a successful product launch’.
Taking place on 4 February 2010, the one-day workshop will lead participants through the current and proposed regulatory requirements, with EAS experts giving tips on long-term product strategies. The workshop, also covers the practical impact of the EU Claims Regulation; an overview of what is harmonised and what not under the current food supplement regulatory framework; the outline of the rules and status for vitamins and minerals across Europe; key areas of opportunity and concern for herbs and other bioactive substances highlighting how the principle of mutual recognition works to avoid barriers to trade in non-harmonised areas; novel foods; and labelling do’s and don’ts.
“Key areas concerning food industry are still not harmonised and manufacturers have to face a number of national approaches and challenges while trying to market food supplements in Europe. Following the novel food Regulation, which has stifled innovation, the claims Regulation comes as a second innovation blocker,” explained EAS Scientific and Regulatory Affairs Manager Efi Leontopoulou, one of the workshop presenters. “With a combination of knowledge, flexibility and strategic thinking, it’s quite possible to overcome the regulatory challenges to marketing products across the whole of the EU. Our workshop aims to explain the impact, prepare industry for the future and highlight ways how to proceed through the maze of food regulation.”
As well as Ms Leontopoulou, the workshop will be presented by the EAS Regulatory Affairs Manager — Nutritional Products, Katarina Wagner, Regulatory Affairs Manager, Stefanie Geiser and EAS food law adviser Elodie Lebastard. Stefanie Geiser added: “At the end of January 2010 the Commission is expected to present Member States a proposal for a first 'Community list' of article 13 claims, based on the first EFSA evaluations. Delays may occur, but our workshop will address latest status of discussions. In addition, we will advise companies on the latest applied EFSA criteria and approach in its health claims evaluation process. In order to help companies develop strategies to navigate the maze of EU regulatory procedures for different claims, potential new options in the EU claims approval process (e.g. for the submission of additional data) and applied transition periods will also be discussed.”
For more information about the upcoming EAS workshop visit http://www.eas.eu/Event.aspx?eventid=12, email [email protected] or contact Cindy Garcet at +32 2 218 14 70.
Notes to Editors:
1. EAS provides strategic consulting advice on European, Asian and international regulation on food and nutritional products. It provides companies with regulatory and strategic advice for the marketing and approval of their products in Europe and Asia.
2. EAS also advises governments, trade associations and companies on the impact of European, Asian and global policy.
3. EAS has offices in Brussels, Italy and Singapore.
4. EAS Italy is a branch of EAS Europe located in northern Italy to follow EFSA developments in Parma closely.
5. For more information on EAS Europe contact EAS, 50 Rue de l’Association, 1000 Brussels, tel: (+32) (0) 2 218 14 70, email [email protected] or visit www.eas.eu
6. For information on EAS Asia contact EAS Strategic Advice Pte Ltd, 3 Killiney Road, 07- 04 Winsland House I, Singapore 239519, tel: (+65) 68 38 12 70, email: [email protected] or visit www.eas.asia.
Disclaimer: Although every effort has been made to provide complete and accurate information, EAS disclaims all warranties, express or implied, as to the accuracy of content on this email. EAS does not endorse or take responsibility for the content or quality of information contained in links to and from this email. EAS does not guarantee the accuracy of or endorse the views or opinions expressed by third parties on this email, and expressly disclaims any and all liability resulting from reliance on such information or opinions.